Recent News and Discussions About Dyax Layoffs
Dyax chops 60 jobs after FDA delay – Fierce Biotech
https://www.fiercebiotech.com/biotech/dyax-chops-60-jobs-after-fda-delay
The layoffs , which will cut more than a third of its staff, should eliminate about $18 million a year in costs. Dyax says it will take a one-time charge of $2 …
Dyax Corp. Layoffs – TheLayoff.com
https://www.thelayoff.com/dyax
Dyax Corp. Layoffs : Downsizing related discussion, postings, questions and answers.
Shire completes $5.9B buyout of Dyax; FDA approves Botox …
https://www.fiercepharma.com/pharma/shire-completes-5-9b-buyout-of-dyax-fda-approves-botox-for-treating-lower-limb-spasticity
Shire completes $5.9B buyout of Dyax ; FDA approves Botox for treating lower limb … Sanofi’s reportedly on the verge of ‘sizable’ job cuts as diabetes …
Shire to Acquire Dyax Corp, expanding and extending …
https://www.fiercepharma.com/pharma/shire-to-acquire-dyax-corp-expanding-and-extending-industry-leading-hereditary-angioedema
(NASDAQ: DYAX ) today announced that Shire will acquire Dyax for $37.30 in cash … The company attributed layoffs to “economic challenges that are impacting …
Biotech Layoffs Hit Hardest In Discovery – Scrip
https://scrip.pharmaintelligence.informa.com/IV001975/
Some of these layoffs look to be part of fairly systematic restructuring … Largely thanks to cuts in research staff, Dyax reduced its workforce by 16% and …
AUY,BLUE,ETRM,ONE,ARQL,BCRX,HGT,SFUN … – Yahoo Finance
https://finance.yahoo.com/quotes/AUY,BLUE,ETRM,ONE,ARQL,BCRX,HGT,SFUN,AUXL,INFI,CATM,UCBI,DYAX,NVAX,WSTL,CYTK,TAST,PTIE,DATA,CTRN,GERN,ICGE,ACI,CYTR,AAV/view/v1/
DYAX · NVAX. 60.63 +1.90%. Novavax, Inc. … Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks. Layoffs at Bluebird Bio Highlight the …
Dyax Scientist I Reviews | Glassdoor
https://www.glassdoor.com/Reviews/Dyax-Scientist-I-Reviews-EI_IE7931.0,4_KO5,16.htm
The company’s culture is very good. Every year employees make a lot donation to charities. Cons. Layoff happened since 3 years ago. Continue reading. Be …
Cubist licenses Dyax’s blood loss prevention drug – Reuters
https://www.reuters.com/article/cubist-dyax-idUKBNG837820080424
Apr 24, 2008 — Cubist Pharmaceuticals Inc said it signed a license and collaboration agreement to develop Dyax Corp’s experimental drug for the prevention …
Analyst says Dyax an attractive takeover candidate (NASDAQ:DYAX …
https://seekingalpha.com/news/2574565-analyst-says-dyax-an-attractive-takeover-candidate?source=content_type%3Areact%7Csection%3ANews%7Csection_asset%3ANews%7Cfirst_level_url%3Asymbol%7Cbutton%3AAuthor%7Clock_status%3ANo%7Cline%3A13
RBC Capital Markets’ Michael Yee says (NASDAQ: DYAX ) would be a juicy acquisition for the likes of Sanofi (NASDAQ:SNY), Alexion Pharmaceuticals (NASDAQ:ALXN) …
Stock Market Today: Stocks Higher as Dyax Deal Boosts Health …
https://www.thestreet.com/markets/stocks-edge-higher-to-start-november-as-asian-markets-sink-13347166
Dyax shares soared 30% after Shire agreed to acquire the drugmaker for $37.30 a share, … The company would not disclose how many layoffs are to expected.